Akorn announces new executive appointments

Akorn Inc., a specialty generic pharmaceutical company, has announced recent executive appointments for roles on the Akorn management team.

Jonathan Kafer, former vice president of account management at Allergan Inc., was appointed executive vice president of sales and marketing. In this newly created role, Kafer will oversee commercial functions for Akorn's business units.

Randall Pollard was appointed vice president and corporate controller. He will oversee accounting and financial reporting functions within Akorn.

Steve Lichter was appointed executive vice president of pharmaceutical operations, and will oversee Akorn's global supply chain and plant operations in this newly created role.

Jaspreet Gill, former vice president of corporate quality at Baxter, was appointed executive vice president of global quality compliance. In her newly created role, Gill will oversee global regulatory compliance for all Akorn manufacturing sites as well as members of Akorn's supply chain.

"It is an honor to welcome Jon, Randy, Steve and Jaspreet to the Akorn team," CEO Raj Rai said. "These four experienced and well-qualified executives bring skills and expertise that will further strengthen our leadership team and prepare Akorn for future growth opportunities."

Headquartered in Lake Forest, Illinois, Akorn develops, manufactures and markets multi-source and branded pharmaceuticals together with prescription animal health products and over-the-counter consumer health products.